Enable Injections
Enable Injections: Innovating patient care with advanced on-body drug delivery systems.
Founded
2011Enable Injections: Innovating patient care with advanced on-body drug delivery systems.
Enable Injections was founded with the core mission of revolutionizing patient care through innovative drug delivery systems. The company focuses on developing and manufacturing on-body delivery solutions designed to enhance the patient experience. Their flagship product, enFuse®, offers a wearable, user-friendly, and flexible drug delivery system that accommodates various viscosities, volumes, delivery times, and administration sites. Enable Injections primarily targets the healthcare market, aiming to provide patients and healthcare providers with more convenient and efficient treatment options.
Notable figures associated with Enable Injections include key investors from prominent venture capital firms specializing in healthcare innovations. The company has achieved significant milestones, including successful clinical trials and partnerships with major pharmaceutical companies. Enable Injections' impact is evident in its contribution to improving patient compliance and comfort, ultimately leading to better health outcomes and streamlined treatment processes.
Companies similar to Enable Injections include ApiJect Systems, Portal Instruments, Inson Medical Systems and Diavibe.
Enable Injections was founded in 2011.
Enable Injections' headquarters is located in Cincinnati, OH, US.
Enable Injections' most recent funding round was for $215M (USD) in January 2022.
As of Jan 27, 2022, Enable Injections has disclosed funding of $347M (USD). Undisclosed round amounts are excluded.
Enable Injections has 181 employees as of Feb 5, 2024.
Diavibe
